Platelet activation and arterial peripheral serotonin turnover in cardiac remodeling associated to aortic stenosis
Open Access
- 20 September 2014
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 90 (1) , 15-19
Abstract
Peripheral serotonin (5‐HT) has been involved in adverse cardiac remodeling and valve fibrosis. The peripheral levels of 5‐HT mainly depend on its release from activated platelets and degradation by monoamine oxidase A (MAO‐A). The SERAOPI study investigated the relationship between arterial serotoninergic system, degree of platelet activation and cardiac remodeling, in patients with aortic valve stenosis (AS). Thirty patients with severe AS and 15 control subjects underwent transthoracic echocardiography, radial, and aortic arterial blood sampling. Measurements of 5‐HT and its MAO‐A‐dependent degradation product, 5‐HIAA, were performed by HPLC. Arterial platelet activation was assessed by flow cytometry analysis of platelet surface expression of P‐selectin and activated integrin GPIIb/IIIa. Activated platelets and arterial plasma 5‐HT increased in AS patients as compared to control subjects (P‐selectin 1.08 ± 0.2MFI vs. 0.49 ± 0.1MFI, P = 0.04; GPIIb/IIIa 0.71 ± 0.1MFI vs. 0.35 ± 0.1MFI; P = 0.0015 and arterial plasma 5‐HT 11.55 ± 1.6 nM vs. 6.18 ± 0.7 nM, P = 0.028, respectively). Moreover, 5‐HT was strongly correlated to left ventricular hypertrophy assessed by echocardiography. The correlation was independent of cardiovascular risk comorbidities and others echocardiographic AS parameters. Finally, plasma 5‐HIAA increased in AS patients (74.64 ± 9.7 nM vs. 37.16 ± 4.1 nM; P = 0.0002) indicating a higher 5‐HT degradation rate by MAO‐A. Platelet activation, arterial circulating serotonin, and serotonin degradation increased in patients with AS. These observations suggest that the serotoninergic system may contribute to the pathogenesis of AS including valve fibrosis and adverse ventricular remodeling. Am. J. Hematol. 90:15–19, 2015.Keywords
Funding Information
- INSERM I2MC
This publication has 29 references indexed in Scilit:
- Asymptomatic Aortic Stenosis in the ElderlyJAMA, 2013
- Exposure of cardiomyocytes to angiotensin II induces over-activation of monoamine oxidase type A: Implications in heart failureEuropean Journal of Pharmacology, 2013
- Transcatheter aortic valve implantation: 10-year anniversary. Part II: clinical implicationsEuropean Heart Journal, 2012
- Drug-induced Valvulopathy: An UpdateToxicologic Pathology, 2010
- Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valvesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Serotonergic drugs and valvular heart diseaseExpert Opinion on Drug Safety, 2009
- Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overloadJournal of Molecular and Cellular Cardiology, 2009
- Burden of valvular heart diseases: a population-based studyThe Lancet, 2006
- Carcinoid heart disease: presentation, diagnosis, and managementHeart, 2004
- Acquired von Willebrand Syndrome in Aortic StenosisNew England Journal of Medicine, 2003